Rhythm Pharmaceuticals Inc

Organisation

222 Berkeley Street, Boston, MA, United States, 02116

Headquarters

Employees

Health Technology

Industry

Hunter Smith

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases. The company's lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is in Phase 3 clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, and other MC4R disorders. The company has licensing agreements with LG Chem, Ltd; Ipsen Pharma S.A.S; Camurus; RareStone Group Ltd.; joint research collaboration with Axovia Therapeutics for developing in bardet-biedl syndrome; and LG Chem, Ltd. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. The company was founded in 2008 and is headquartered in Boston, Massachusetts.

Price

Target

Rhythm Pharmaceuticals Inc (RYTM) Price vs Consensus Price Target

As per the chart shown above, analysts believe that the Rhythm Pharmaceuticals Inc (RYTM) share price will touch around $141.57 in next 12-months.

Currently 15 wall-street analysts regularly analyze the financials of Rhythm Pharmaceuticals Inc on a frequent basis to provide recommendations along with target share price. 15 analysts offering 12-month price forecasts for Rhythm Pharmaceuticals Inc (RYTM) have a share price target of $141.57. This median of share price forecast represents a 39.8% upside from the latest price of $101.27 as on 19.02.26.

Rhythm Pharmaceuticals Inc (RYTM) Share Price Forecast

Home

US Stocks

Rhythm Pharmaceuticals Inc (RYTM)

Rhythm Pharmaceuticals Inc Stock Forecast

Rhythm Pharmaceuticals Inc Stock Forecast & Price Target (Analyst Recommendation) | INDmoney

Percentage Difference

Rhythm Pharmaceuticals Inc (RYTM): Difference between Current Price & Median Forecasted Price

Below is a chart showing the percentage difference between Rhythm Pharmaceuticals Inc's share price and its median forecast price. As on 19.02.26, the difference is -24.43%

Rhythm Pharmaceuticals Inc Forecast and Target Price

Rhythm Pharmaceuticals Inc (RYTM) Share Price Forecast

Rhythm Pharmaceuticals Inc (RYTM) Price vs Consensus Price Target

Rhythm Pharmaceuticals Inc (RYTM) Share Price Forecast v/s Share Price Today

Rhythm Pharmaceuticals Inc (RYTM): Difference between Current Price & Median Forecasted Price

Rhythm Pharmaceuticals Inc (RYTM) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

200 Day Moving Average v/s Current Share Price